The leader in developing and commercializing innovative biomarker products and services
Myriad RBM, Inc. uses proprietary Multi-Analyte Profiling (MAP) technology to make life science research and drug and diagnostic development programs more efficient and effective. Whether measuring hundreds of biomarkers or simply a few, our approach provides reproducible, quantitative immunoassay data from a small sample volume at a cost-effective price. Myriad RBM is CLIA certified and supports GLP studies.

---

Myriad RBM’s Strategic Biomarker Services can provide solutions to help discover and validate biomarker patterns for use in clinical trials and companion diagnostic applications.
Learn More »